Real-time enrollment status for this thrombotic thrombocytopenic purpura clinical trial
Current Status
Completed
Checked: June 1, 2026 at 10:13 PM UTC
| NCT Number | NCT05714969 |
| Recruiting Status | Completed |
| Condition | Thrombotic Thrombocytopenic Purpura |
| Phase | Clinical Trial |
| Target Enrollment | 33 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Takeda |
| Last Updated on CT.gov | April 28, 2026 (Apr 28, 2026) |
As of June 1, 2026: Clinical trial NCT05714969 is currently completed participants. This clinical trial study for thrombotic thrombocytopenic purpura is not currently accepting new participants at 12 locations across the United States. The study is sponsored by Takeda. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05714969 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05714969 was last updated Apr 28, 2026 (April 28, 2026). HelloStudys verifies this status automatically.